Blue Trust Inc’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2
Closed -$103 2555
2026
Q1
$103 Buy
+2
New +$140 ﹤0.01% 2452
2025
Q2
Sell
-62
Closed -$9.88K 2534
2025
Q1
$9.88K Buy
62
+5
+9% +$905 ﹤0.01% 1898
2024
Q4
$10.6K Sell
57
-19
-25% -$3.69K ﹤0.01% 1819
2024
Q3
$10.2K Hold
76
﹤0.01% 2185
2024
Q2
$16.3K Buy
76
+19
+33% +$3.6K ﹤0.01% 1749
2024
Q1
$12.2K Sell
57
-27
-32% -$5.29K ﹤0.01% 1388
2023
Q4
$17K Buy
84
+50
+147% +$8.1K ﹤0.01% 1363
2023
Q3
$11K Buy
34
+4
+13% +$1.01K ﹤0.01% 1384
2023
Q2
$7K Sell
30
-30
-50% -$8.57K ﹤0.01% 1421
2023
Q1
$15K Buy
60
+30
+100% +$7.58K ﹤0.01% 1483
2022
Q4
$5K Sell
30
-28
-48% -$5.97K ﹤0.01% 1724
2022
Q3
$11K Buy
58
+57
+5,700% +$11.5K ﹤0.01% 1299
2022
Q2
$0 Buy
+1
New +$199 ﹤0.01% 1941

Other funds holding INSP

Blue Trust Inc's INSP Position: Q2 2026 in Review

Blue Trust Inc sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 2 shares — an estimated $103 sold.

Blue Trust Inc first reported a position in INSP in Q2 2022 and held it in 13 quarters. The position peaked at $17K in Q4 2023. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Blue Trust Inc reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Blue Trust Inc sold 2 Inspire Medical Systems shares in Q2 2026, an estimated $103.
  • Blue Trust Inc first reported a position in Inspire Medical Systems in Q2 2022 and held it in 13 quarters.
  • Blue Trust Inc's Inspire Medical Systems position peaked at $17K in Q4 2023.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.